The Path to Personalized Treatment in KRAS-Mutant Non-Small Cell Lung Cancer: A Review of Targeted Therapies and Immunotherapy

PURPOSE OF REVIEW: To summarize the targeted therapies and immunotherapy of Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant non-small cell lung cancer (NSCLC), and discuss the ongoing clinical trials. RECENT FINDINGS: KRAS mutations occur in about 30% of patients with NSCLC and are the seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Chun-Lu, Liu, Yu-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767706/
https://www.ncbi.nlm.nih.gov/pubmed/36561983
http://dx.doi.org/10.2147/CMAR.S387665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767706/
https://www.ncbi.nlm.nih.gov/pubmed/36561983
http://dx.doi.org/10.2147/CMAR.S387665

Ejemplares similares